ANIX Financials

Income Statement
MetricQ3 2026Q2 2026Q2 2026Q1 2026Q1 2026
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
2.7M
+3.4%
2.6M
+0.0%
2.6M
-2.5%
2.7M
+0.0%
2.7M
R&D
1.3M
+5.4%
1.3M
+0.0%
1.3M
+14.2%
1.1M
+0.0%
1.1M
SG&A
1.4M
+1.6%
1.4M
+0.0%
1.4M
-13.9%
1.6M
+0.0%
1.6M
Operating Income
-2737000
-3.4%
-2647000
+0.0%
-2647000
+2.5%
-2716000
+0.0%
-2716000
EBITDA
-2737000
-3.4%
-2647000
+0.0%
-2647000
+2.5%
-2716000
+0.0%
-2716000
Net Income
-2625000
-3.5%
-2536000
+0.0%
-2536000
+1.9%
-2585000
+0.0%
-2585000
EPS (Basic)
$-0.08
-14.3%
$-0.07
+0.0%
$-0.07
+12.5%
$-0.08
+0.0%
$-0.08
EPS (Diluted)
$-0.08
-14.3%
$-0.07
+0.0%
$-0.07
+12.5%
$-0.08
+0.0%
$-0.08
Shares (Diluted)
34.2M
+1.8%
33.6M
+0.0%
33.6M
+1.1%
33.2M
+0.0%
33.2M
Anixa Biosciences (ANIX) โ€” Financials